Intelligence and fetal alcohol spectrum disorders
Journal of Population Therapeutics and Clinical Pharmacology · 2019
DOI: 10.15586/jptcp.v24i3.643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Population Therapeutics and Clinical Pharmacology, 2019. Verfasst von Vanessa K. De L. Ferreira und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The studies on intelligence in individuals with fetal alcohol exposure are conflicting. Some have found a relevant impairment in this population, while others found results that were consistent with the population at large.
Objectives
Describe the results of studies on intelligence in individuals with Fetal Alcohol Spectrum Disorders.
Methods
Indexed articles of the last 10 years were selected for an integrative literature review. After inclusion and exclusion criteria were satisfied 37 articles were selected.
Results
General intelligence, both verbal and non-verbal, is impaired in people who are prenatally exposed to alcohol. There is a tendency to a greater reduction in the Freedom from Distractibility/Working Memory Index of Wechsler Scales.
Conclusions
Reduction in intelligence seems to occur on a continuum similar to the fetal alcohol spectrum. The reduction of the Freedom from Distractibility/Working Memory Index appears to be a reflection of a greater impairment of mathematical ability.
Zitieren
APA
Ferreira, V. K. D. L., & Cruz, M. S. (2019). Intelligence and fetal alcohol spectrum disorders. Journal of Population Therapeutics and Clinical Pharmacology. https://doi.org/10.15586/jptcp.v24i3.643
Vancouver
Ferreira VKDL, Cruz MS. Intelligence and fetal alcohol spectrum disorders. Journal of Population Therapeutics and Clinical Pharmacology. 2019. doi:10.15586/jptcp.v24i3.643
BibTeX
@article{Ferreira2019,
author = {Ferreira, Vanessa K. De L. and Cruz, Marcelo S.},
title = {Intelligence and fetal alcohol spectrum disorders},
journal = {Journal of Population Therapeutics and Clinical Pharmacology},
year = {2019},
doi = {10.15586/jptcp.v24i3.643}
}
EUVIMED